Homoharringtonine alone or combined with other agents for use in treating chronic myelogenous leukemia resistant or intolerant to protein kinase inhibitors other than STI 571

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP09172828.7

公开号：

EP2177223B9

申请日:

2002.09.05

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The present invention concerns a method of treating chronic myelogenous leukemia, a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia in a subject animal, comprising:(a) selecting or identifying an animal suffering from chronic myelogenous leukemia or a related myeloproliferative disorder and showing resistance or intolerance to treatment with STI571 and(b) administering to the animal homoharringtonine.In a preferred embodiment, the animal is a human being.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/